"Liquid biopsy analysis provides a noninvasive and facile tool for early detection, diagnosis, and recurrence surveillance of urological cancer," writes Jim Lu, MD, PhD.

A panelist discusses how different abiraterone formulations require specific steroid combinations—prednisone with traditional abiraterone and prednisolone with microformulation—and the importance of ...

Benjamin M. Brucker, MD, outlines considerations surrounding pre-procedure urinalysis, prophylactic periprocedural antibiotics, and optimal dosing regimens for onabotA administration.

A notable finding was that 35% of these NMIBC patients exhibited ctDNA positivity. A notable finding was that 35% of these NMIBC patients exhibited ctDNA positivity, which was an unexpected and ...

Vignesh T. Packiam, MD, outlines the mechanism of action for detalimogene voraplasmid as well as its potential benefits in terms of storage and dosing.

In a recent interview with Urology Times ®, Nicolette G. Payne, MD, a urology resident at Mayo Clinic in Phoenix, Arizona, elaborated on the underlying mechanisms contributing to burnout among ...

Welcome to Urology Times’ ® monthly FDA update! June was a busy month for urological regulatory news, featuring new approvals for prostate cancer, bladder cancer, benign prostatic hyperplasia (BPH), ...

Leflutrozole, an aromatase inhibitor, is being tested in a phase 2 trial for male infertility due to low testosterone levels. The trial will enroll 200 patients, assessing leflutrozole's impact on ...

Gedatolisib and darolutamide combination showed a 66% 6-month rPFS in mCRPC patients, indicating promising preliminary efficacy. Safety data revealed no treatment discontinuations or dose reductions ...

Key Takeaways The TOBY Test uses AI and gas chromatography–mass spectrometry to analyze urine for early cancer detection, offering a significant advantage over current methods. The FDA's breakthrough ...

A comprehensive guide to the key regulatory decisions and conferences slated for Q3 of 2025.

Justin Dubin, MD, touches on the current landscape of men’s health, with a specific focus on the advent of AI.